期刊
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 28, 期 9, 页码 1140-1146出版社
WILEY
DOI: 10.1111/j.1365-2036.2008.03795.x
关键词
-
资金
- University of Utah and Salt Lake Veterans Administration
- Esai
- TAP and AstraZeneca. J. Fang
- AstraZeneca, Olympus, Esai, Wilson Cook, Boston Scientific
Background Eosinophilic oesophagitis (EoO) may be a common finding in adults presenting with dysphagia. Aim To identify the risk factors and prevalence of EoO in an adult population with dysphagia. Methods All patients with dysphagia referred for an upper endoscopy (EGD) were asked to participate. Patients completed a detailed questionnaire followed by EGD with four quadrant biopsies in the distal and mid-oesophagus. Primary endpoint was the prevalence of EoO; secondary endpoints included age, gender, asthma, food allergies, gastro-oesophageal reflux disease/dysphagia score and endoscopic findings. Results Two hundred and sixty-one patients enrolled between December 2005 and January 2007. Thirty-one patients (12%) met pathological criteria for EoO. There was no difference in EoO prevalence within each gender. Mean age of EoO patients was 42 +/- 15 vs. 61 +/- 15 for non-EoO patients (P < 0.001). EoO was diagnosed in 35% of patients < 50 years of age. EoO was present in 22% of asthmatics vs. 9% non-asthmatics (P < 0.01). EoO was present in 36.8% of patients with self-reported food allergies vs. 9.3% those without allergy (P < 0.001). A 13/31(42%) of EoO patients did not have the classic EGD findings (rings +/- furrows) and would have been missed without oesophageal biopsies. Conclusions Eosinophilic oesophagitis was diagnosed in 12% of the patients presenting with dysphagia with relative risk of 9.5 if age < 50 years. Oesophageal biopsies are warranted in patients presenting with dysphagia especially in the younger population. Patients may not present with classic endoscopic findings and EoO can be missed without biopsies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据